This is the authors' abstract. We don't add key points for this paper.
The Atopic Dermatitis Control Tool (ADCT) is a validated 6-item tool used in clinical trials to assess eczema control in adolescents and adults. Two versions of the ADCT were recently created using FDA-recommended methodology for caregivers of children 6 months-11 years old (Caregiver ADCT; score range: 0-24, higher score indicates worse control, 1-week recall) and for children ages 8-11 (Child Eczema Control Tool [ECT]). Our initial psychometric validation of the Caregiver ADCT (first 100 caregivers recruited) demonstrated no floor or ceiling effects for response distributions except for a floor effect for "sleep trouble nights" (47% scored the least severe option, 47/100). There were strong (r≥0.57, p<0.001) inter-item correlations and construct validity (r≥0.59, p<0.001) consistent with a priori hypotheses. The Caregiver ADCT showed strong internal consistency (Cronbach's α 0.92, 95% CI: 0.90-0.94). A score ≥7 was identified as an optimum threshold to identify children whose eczema is "not in control".
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: